Twin Tree Management, LP Invitae Corp Transaction History

Twin Tree Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$6.28 - $15.59 $1,601 - $3,975	-255 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$14.7 - $28.67 $3,351 - $6,536	228 Added 844.44%	255 $4,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $656 - $907	27 New	27 $1,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $56,197 - $87,021	-2,154 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $447,665 - $770,889	-13,541 Reduced 86.28%	2,154 $82,000
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $613,517 - $900,893	15,695 New	15,695 $656,000
Q2 2019 Aug 12, 2019	SELL	$17.37 - $26.27 $5,732 - $8,669	-330 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$10.65 - $25.75 $3,514 - $8,497	330 New	330 $8,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.